|
|
||||||||
Clinical Sciences |
nierz–Cabala5
Nuclear Medicine Unit,1 Department of Endocrinology; Department of Nephrology,2 Jagiellonian University Medical School, Cracow; Radioisotope Centre POLATOM,3 Institute of Atomic Energy, Otwock–Swierk; Department of Radiopharmaceuticals,4 National Medicines Institute, Warsaw; Clinical Biochemistry,5 Jagiellonian University Medical School, Cracow, Poland
Correspondence to: T. Stompór, Department of Nephrology, Jagiellonian University, 15c Kopernika Str., 31-501 Cracow, Poland. stompin{at}mp.pl
Background: Patients with end-stage renal disease
(ESRD) suffer from markedly increased cardiovascular morbidity and mortality.
Common carotid artery (CCA) intima-media thickness (IMT) assessment and CCA
plaque identification using ultrasound are well-recognized tools for
identification and monitoring of atherosclerosis. A new method for monitoring
the inflammatory status of plaque, namely radiolabeled interleukin-2 (IL-2)
scintigraphy, was proposed recently. The aim of this pilot study was to
perform 123I-labeled-IL-2 carotid plaque scintigraphy in ESRD
patients treated with peritoneal dialysis and to correlate obtained results
with ultrasound assessment of CCA and selected inflammatory markers.
Methods: CCA-IMT was measured and CCA plaques were
identified by ultrasound in 10 patients (5 women, 5 men; mean age 62.4
± 10.4 years; median peritoneal dialysis duration 32.5 months, range 12
– 55 months) with advanced cardiovascular comorbidity. Following CCA
ultrasound, 123I-labeled IL-2 carotid plaque scintigraphy was
performed. Several biomarkers of inflammation and atherosclerosis were also
measured in all patients.
Results: Mean target/non-target ratio for focal
123I-IL-2 uptake within the plaque was 3.15 ± 0.54, and mean
IMT from the site of the scintigraphy analysis was 0.975 ± 0.337 mm.
Highly significant correlation was found between CCA-IMT and a
target/non-target ratio for focal 123I-IL-2 uptake in a
corresponding artery (R = 0.92, p = 0.01). However, no
significant correlations were found between target/non-target ratio for focal
123I-IL-2 uptake and levels of measured biomarkers.
Conclusions: Our preliminary results suggest potential
for identification of an inflamed (vulnerable) plaque using IL-2 scintigraphy
in ESRD patients with cardiovascular comorbidities.
KEY WORDS: Atherosclerosis; atherosclerotic plaque; 123I-interleukin-2 plaque scintigraphy; intima-media thickness.
Received 12 February 2008; accepted 15 October 2008.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |